Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation

被引:53
作者
Inai, K [1 ]
Nakanishi, T [1 ]
Nakazawa, M [1 ]
机构
[1] Tokyo Womens Med Univ, Heart Inst Japan, Dept Pediat Cardiol, Shinjuku Ku, Tokyo 1628666, Japan
关键词
D O I
10.1016/j.ahj.2004.10.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims We tested the hypothesis that neurohumoral activation could correlate with exercise tolerance and have a prognostic value in patients late after Fontan operation. Methods and Results We studied 50 consecutive patients after the Fontan operation and 10 age-matched normal controls. We measured brain and atrial natriuretic peptides, norepinephrine (NE), plasma rennin activity, aldosterone, angiotensin 11, and endothelin and investigated the relationship of neurohumoral factors with exercise tolerance and central hemodynamics. We also evaluated the prognostic predictive value of these factors. All factors were significantly higher in the patients than in controls, but no factor correlated with peak oxygen consumption (peak VO2). There were significant correlations of atrial natriuretic peptide with cardiac index, NE with left ventricular ejection fraction (LVEF), and pulmonary arterial wedge pressure. After 4 years' follow-up, univariate Cox proportional hazards analysis showed that peak VO2 and LVEF could significantly predict the long-term event-free ratio. In multivariate analysis, LVEF and NE have a significant predictive value. In Kaplan-Meier event-free curves, NE combined with peak VO2 showed a significant predictive value. Conclusions Activated neurohumoral factors are not determinants of exercise tolerance in patients late after the Fontan operation. The plasma level of NE combined with peak VO2 has a prognostic predictive value in these patients.
引用
收藏
页码:588 / 594
页数:7
相关论文
共 23 条
[1]   Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT) [J].
Anand, IS ;
Fisher, LD ;
Chiang, YT ;
Latini, R ;
Masson, S ;
Maggioni, AP ;
Glazer, RD ;
Tognoni, G ;
Cohn, JN .
CIRCULATION, 2003, 107 (09) :1278-1283
[2]   Immunologic profile of patients with protein-losing enteropathy complicating congenital heart disease [J].
Cheung, YF ;
Tsang, HYH ;
Kwok, JSY .
PEDIATRIC CARDIOLOGY, 2002, 23 (06) :587-593
[3]   Global impairment of cardiac autonomic nervous activity late after the Fontan operation [J].
Davos, CH ;
Francis, DP ;
Leenarts, MFE ;
Yap, SC ;
Li, W ;
Davlouros, PA ;
Wensel, R ;
Coats, AJS ;
Piepoli, M ;
Sreeram, N ;
Gatzoulis, MA .
CIRCULATION, 2003, 108 (10) :180-185
[4]   SURGICAL REPAIR OF TRICUSPID ATRESIA [J].
FONTAN, F ;
BAUDET, E .
THORAX, 1971, 26 (03) :240-+
[5]  
Freedom RM, 2000, CARDIOL YOUNG, V10, P307
[6]   Changes of neurohumoral parameters and endothelin-1 in response to exercise in patients with mild to moderate congestive heart failure [J].
Genth-Zotz, S ;
Zotz, RJ ;
Cobaugh, M ;
van Veldhuisen, DJ ;
Netzer, T ;
Meyer, J ;
Darius, H .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 66 (02) :137-142
[7]   EXERCISE RESPONSES IN PATIENTS WITH CONGENITAL HEART-DISEASE AFTER FONTAN REPAIR - PATTERNS AND DETERMINANTS OF PERFORMANCE [J].
GEWILLIG, MH ;
LUNDSTROM, UR ;
BULL, C ;
WYSE, RKH ;
DEANFIELD, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (06) :1424-1432
[8]   Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation [J].
Ghai, A ;
Harris, L ;
Harrison, DA ;
Webb, GD ;
Siu, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :585-592
[9]  
ISHIKAWA S, 1995, J CARDIOVASC PHARM, V26, pS429
[10]   Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure [J].
Isnard, R ;
Pousset, F ;
Trochu, JN ;
Chafirovskaïa, O ;
Carayon, A ;
Golmard, JL ;
Lechat, P ;
Thomas, D ;
Bouhour, JB ;
Komajda, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (04) :417-421